Skip to Content

756 (Temozolomide 250 mg)

Pill with imprint 756 is White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 756

Temozolomide

Imprint
756
Strength
250 mg
Color
White
Size
24.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0756
Inactive Ingredients
alcohol, ammonia, lactose anhydrous, butyl alcohol, ferrosoferric oxide, gelatin, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, silicon dioxide, sodium lauryl sulfate, sodium starch glycolate type B potato, stearic acid, tartaric acid, titanium dioxide, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "756"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.